BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Targacept, Inc. 

200 East First Street
Suite 300
Winston-Salem  North Carolina  27101-4165  U.S.A.
Phone: 336-480-2100 Fax: 336-480-2107


SEARCH JOBS
Targacept, Inc. is developing a diverse pipeline of innovative NNR Therapeutics™ for difficult-to-treat diseases and disorders of the nervous system. NNR Therapeutics selectively modulate the activity of specific neuronal nicotinic receptors, a unique class of proteins that regulate vital biological functions that are impaired in various disease states. Targacept's lead program, TC-5214, is being co-developed with AstraZeneca and is in Phase 3 clinical trials as an adjunct treatment for major depressive disorder. Targacept leverages its scientific leadership and proprietary drug discovery platform Pentad™ to generate novel small molecule product candidates to fuel its pipeline and attract significant collaborations with global pharmaceutical companies.

Targacept’s news releases are available on its website at www.targacept.com.


 Key Statistics


Email: heather.savelle@targacept.com
Ownership: Public

Web Site: Targacept, Inc.
Employees: 120
Symbol: TRGT
 









 Company News
Targacept, Inc. (TRGT) To Present At The 13th Annual Needham Healthcare Conference 4/2/2014 7:47:03 AM    More...
Targacept, Inc. (TRGT) Reports Fourth Quarter And 2013 Financial Results 2/13/2014 8:04:36 AM    More...
Targacept, Inc. (TRGT) Completes Recruitment In Phase 2b Overactive Bladder Trial Of TC-5214 2/10/2014 9:46:40 AM    More...
Targacept, Inc. (TRGT) Appoints John P. Richard As Chairman Of The Board Of Directors 1/8/2014 8:51:54 AM    More...
Targacept, Inc. (TRGT) Announces Negative Top-Line Results From Phase 2b Clinical Trial Of TC-5619 In Schizophrenia 12/17/2013 9:52:54 AM    More...
Targacept, Inc. (TRGT) Announces Negative Top-Line Results From Phase 2b Clinical Trial Of TC-5619 In Schizophrenia 12/17/2013 7:29:07 AM    More...
Targacept, Inc. (TRGT) Announces Presentations At Upcoming Conferences 11/14/2013 9:37:12 AM    More...
Targacept, Inc. (TRGT) Reports Third Quarter 2013 Financial Results 11/5/2013 7:12:02 AM    More...
Targacept, Inc. (TRGT) to Report Third Quarter 2013 Financial Results on November 5, 2013 10/29/2013 6:49:01 AM    More...
Targacept, Inc. (TRGT) Reports Second Quarter 2013 Financial Results 8/6/2013 7:40:33 AM    More...
12345678910...

//-->